Differential regulation of kallikrein, kininogen, and kallikrein-binding protein in arterial hypertensive rats

American Journal of Physiology

Volumn 271, Issue 1 PART 2, 1996, Pages

  Chao, Caroline ^a   Madeddu, Paolo ^b   Wang, Cindy ^a   Liang, Yumei ^a   Chao, Lee ^b   Chao, Julie ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Nitric oxide synthase; Tissue kallikrein

Indexed keywords

ALPHA 1 ANTITRYPSIN; BETA ACTIN; BINDING PROTEIN; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; KALLIKREIN; KALLIKREIN BINDING PROTEIN; KININOGEN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HYPERTENSION; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ARGININE; ASIALOGLYCOPROTEIN RECEPTOR; CARDIOVASCULAR SYSTEM; GENE EXPRESSION; HYPERTENSION; KALLIKREINS; KININOGENS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ; RECEPTORS, CELL SURFACE;

EID: 0029758185     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.271.1.f78     Document Type: Article

References (44)

1. Ader, J. L., D. M. Pollock, M. I. Butterfleld, and W. J. Arendshorst. Abnormalities in kallikrein excretion in spontaneously hypertensive rats. Am. J. Physiol. 248 (Renal Fluid Electrolyte Physiol. 17): F396-F403, 1985.
2. Albertini, R., R. Ladron de Guevara, F. Asenjo, and M. Boric. Effect of renal nerve stimulation on urine and tissue kininogenase activity in cats. Hypertension Dallas 3, Suppl. II: II50-II54, 1981.
3. Berry, T. D., S. J. Hasstedt, S. C. Hunt, L. L. Wu, J. B. Smith, K. O. Ash, H. Kuida, and R. R. Williams. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension Dallas 13: 3-8, 1989.
4. Bhoola, K. D., C. D. Figueroa, and K. Worthy. Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev. 44: 1-80, 1992.
5. Bjornstad-Ostensen, A., and T. Berg. The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostais following an acute kinin-induced hypotension. Er. J. Pharmacol. 113: 1567-1573, 1994.
6. Chao, J., K. X. Chai, L. M. Chen, W. Xiong, S. Chao, C. Woodley-Miller, L. X. Wang, H. S. Lu, and L. Chao. Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. J. Biol. Chem. 265: 16394-16401, 1990.
7. Chao, J., and L. Chao. A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats. J. Hypertens. 6: 551-557, 1988.
8. Chao, J., and H. S. Margolius. Isozymes of rat urinary kallikrein. Biochem. Pharmacol. 28: 2071-2079, 1979.
9. Chao, J., J. Simson, A. P. Chung, L. M. Chen, and L. Chao. Regulation of kininogen gene expression and localization in the lung after monocrotaline-induced pulmonary hypertension in rats. Proc. Soc. Exp. Biol. Med. 203: 243-250, 1993.
10. Chao, J., C. Swain, S. Chao, W. Xiong, and L. Chao. Tissue distribution and kininogen gene expression after acute-phase inflammation. Biochim. Biophys. Acta 964: 329-339, 1988.
11. Chao, S., K. X. Chai, L. Chao, and J. Chao. Molecular cloning and primary structure of rat al-antitrypsin. Biochemistry 29: 323-329, 1990.
12. Chao, S., L. Chao, and J. Chao. Enhanced specificity in immunoscreening of expression cDNA clones using radiolabeled antigen overlay. Biotechniques 7: 68-72, 1989.
13. Dananberg, J., R. S. Sider, and J. Grekin. Sustained hypertension induced by orally administered nitro-L-arginine. Hypertension Dallas 21: 359-363, 1993.
14. Gerald, W. L., J. Chao, and L. Chao. Immunological identification of rat tissue kallikrein cDNA and characterization of the kallikrein gene family. Biochim. Biophys. Acta 866: 1-14, 1986.
15. Jover, B., A. Herizi, F. Ventre, M. Fupon, and A. Miniran. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension Dallas 21: 944-948, 1993.
16. Hu, L., Manning, D., amd M. W. Brands. Long-term cardiovascular role of nitric oxide in conscious rats. Hypertension Dallas 23: 185-194, 1994.
17. Lahera, V., M. G. Salom, M. J. Fiksen-Olsen, and J, C. Romero. Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am. J. Hypertens. 4: 260-262, 1991.
18. Lahera, V., M. G. Salom, F. Miranda-Guardiola, S. Moncada, and J. C. Romero. Effects of A-nitro-L-arginine methyl ester on renal function and blood pressure. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F1033-F1037, 1991.
19. Lantelme, P., M. Lo, and J. Sassard. Decreased cardiac baroreflex sensitivity is not due to cardiac hypertrophy in iV-nitro-L-arginine methyl ester-induced hypertension. J. Hypertens. 12: 791-795.
20. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
21. Ma, J., Z. Yang, J. Chao, and L. Chao. Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. J. Biol. Chem. 270: 451-455, 1995.
22. Madeddu, P., P. Pinna-Parpaglia, M. P. Dementis, M. V. Varoni, C. Fattaccio, V. Anania, and N. Glorioso. Early blockade of bradykinin 82 receptors alters the adult cardiovascular phenotype in rats. Hypertension Dallas 25: 453-459, 1995.
23. Madeddu, P., P. Pinna-Parpaglia, M. P. Demontis, M. V. Varoni, C. Fattaccio, and N. Glorioso. Chronic inhibition of bradykinin B2-receptors enhances the slow vasopressor response to angiotensin II. Hypertension Dallas 21: 980-984, 1993.
24. Madeddu, P., P. Pinna-Parpaglia, M. P. Demontis, M. V. Varoni, C. Fattaccio, G. C. Tonolo, C. Troffa, and N. Glorioso. Bradykinin B2-receptor blockade facilitates deoxycortico-sterone-salt hypertension. Hypertension Dallas 21: 980-984, 1993.
25. Majima, M., O. Yoshida, H. Mihara, T. Muto, S., Mizogami, Y. Kuribayashi, M. Katon, and S. Oh-ishi. High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats. Hypertension Dallas 22: 705-714, 1993.
26. Margolius, H. S. Kallikreins, and kinins: some unanswered questions about system characteristics and roles in human disease. Hypertension Dallas 26: 221-229, 1995.
27. Margolius, H. S., R. Geller, W. De Jong, J. J. Pisano, and A. Sjoerdsma. Altered urinary kallikrein excretion in rats with hypertension. Giro. Res. 30: 358-362, 1972.
28. Matsuoka, H., Nishida, H., Nomura, G., B. N. Van Vliet, and H. Toshima. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension Dallas 23: part 2: 971-975, 1994.
29. Mombouli, J. V., S. Illiano, T. Nagao, and P. M. Vanhoutte. The potentiation of bradykinin-induced relaxations by perindoprilat in canine coronary arteries involves both nitric oxide and endothelium-derived hyperpolarizing factor. Circ. Res. 71: 137-144, 1991.
30. Muller-EsterI, W. Kininogens, kinins, and kinships. Thromb. Haemostasis 61: 2-6, 1989.
31. Pollock, D. M., J. S. Polakowiski, B. J. Divish, and T. J. Opgenorth. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension Dallas 21: 660-666, 1993.
32. Pravenec, M., V. Kren, J. Rimes, G. Scicli, O. A. Carretero, L. Simonet, and T. W. Kurtz. Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension Dallas 17: 242-246, 1991.
33. Rhaleb, N. E., S. Telemaque, N. Roussi, N. Dion, D. Jukic, G. Drapeau, and D. Regoli. Structure-activity studies of bradykinin and related peptides: B2-receptor antagonists. Hypertension Dallas 17: 107-115, 1991.
34. Salazar, F. J., A. Alberola, J. M. Pinilla, J. C. Romero, and T. Quesada. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension Dallas 22: 49-55, 1993.
35. Sambrook, J., E. F. Fritsch, and T. Maniatis. Extraction of RNA with guanidine thiocyanate followed by centrifugation in cesium chloride solutions. In: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989, p. 7.19-7.22.
36. Serveau, C., T. Toreau, G. X. Zhou, J. Chao, and F. Gauthier. Inhibition of rat tissue kallikrein gene family members by rat kallikrein-binding protein and al-proteinase inhibitor. FEES Lett. 309: 405-408, 1992.
37. Shimamoto, K., H. S. Margolius, J. Chao, and A. R. Crosswell. A direct radioimmunoassay of rat urinary kallikrein and comparison with other measures of urinary kallikrein activity. J. Lab. Clin. Med. 94: 172-179, 1979.
38. Shimamoto, K, S. Tonaka, T. Nakao, T. Ando, Y. Nakahashi, M. Sakuma, and M. Miyahara. Measurement of urinary kallikrein activity by kinin radioimmunoassay. Jpn. Cire. J. 43: 147-152, 1979.
39. Wang, C., J. Chao, and L. Chao. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J. Clin. Invest. 95: 1710-1716, 1995.
40. Wang, J., W. Xiong, Z. Yang, T. Davis, M. J. Dewey, J. Chao, and L. Chao. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension Dallas 23: 236-243, 1994.
41. Woodley-Miller, C., J. Chao, and L. Chao. Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. J. Hypertens. 7: 865-871, 1989.
42. Xiong, W., J. Chao, and L. Chao. Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hypertension Dallas 25: 715-719, 1995.
43. Xiong, W., C. Q. Tang, G. X., Zhou, L. Chao, and J. Chao. In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein. J. Lab. Clin. Med. 119: 514-521, 1992.
44. Zinner, S. H., H. S. Margolius, B. R. Rosner, and E. H. Kass. Stability of blood pressure rank and urinary kallikrein concentration in childhood. Circulation 58: 908-915, 1978.